INTERACTION BETWEEN DIGOXIN AND INDOMETHACIN OR IBUPROFEN

被引:21
作者
JORGENSEN, HS [1 ]
CHRISTENSEN, HR [1 ]
KAMPMANN, JP [1 ]
机构
[1] BISPEBJERG HOSP,MED DEPT P,DK-2400 COPENHAGEN,DENMARK
关键词
DIGOXIN; INDOMETHACIN; IBUPROFEN; INTERACTION;
D O I
10.1111/j.1365-2125.1991.tb03867.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
To study a potential interaction between digoxin and two non-steroid anti-inflammatory drugs, indomethacin (50 mg three times daily) and ibuprofen (600 mg three times daily) were given for 10 days to 10 and 8 patients, respectively, on chronic digoxin treatment. Serum digoxin measured by fluorescencepolarisation immunoassay increased significantly (P < 0.05) during treatment with indomethacin from pre-treatment values of 0.73 +/- 0.34 nmol l-1 (mean +/- s.d.) to a mean value of 1.02 +/- 43 nmol l-1, while administration of ibuprofen did not change the steady state serum concentration of digoxin. The result demonstrates that some non-steroidal anti-inflammatory drugs such as indomethacin increase serum digoxin to levels high in the therapeutic range. This should be taken into consideration when co-administrating other drugs known to increase the serum concentration of digoxin such as several antiarrhythmics.
引用
收藏
页码:108 / 110
页数:3
相关论文
共 11 条
[1]  
CLARK DR, 1986, CLIN CHEM, V32, P381
[2]  
DOERING VW, 1983, ARZNEIMITTEL-FORSCH, V33, P167
[3]   SERUM DIGOXIN CONCENTRATION - INCREASE AFTER REST IN DIFFERENT BODY POSITIONS [J].
EDNER, M .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 15 (03) :508-509
[4]   KINETICS OF THE DIGOXIN-ASPIRIN COMBINATION [J].
FENSTER, PE ;
COMESS, KA ;
HANSON, CD ;
FINLEY, PR .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (04) :428-430
[5]   PHARMACOKINETICS OF DIGOXIN ALONE AND IN THE PRESENCE OF INDOMETHACIN THERAPY [J].
FINCH, MB ;
JOHNSTON, GD ;
KELLY, JG ;
MCDEVITT, DG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (03) :353-355
[6]  
KOREN G, 1984, PEDIATR PHARMACOL, V4, P25
[7]   CLINICAL PHARMACOKINETIC SIGNIFICANCE OF THE RENAL TUBULAR SECRETION OF DIGOXIN [J].
KOREN, G .
CLINICAL PHARMACOKINETICS, 1987, 13 (05) :334-343
[8]  
QUATTROCCHI FP, 1983, DRUGS INTELL CLIN PH, V7, P286
[9]  
SCHIMMEL MS, 1980, CLIN PEDIATR NOV, P768
[10]  
ZOLLER B, 1982, EUR J RHEUMATOL INFL, V5, P82